Clinical Trial

DIPB vs. SIFIB for Postoperative Analgesia After Hip Surgery

Recruiting
View on ClinicalTrials.gov →
Summary
This randomized, double-blind clinical trial aims to compare the effectiveness of the Deep Iliacus Plane Block (DIPB) and the Suprainguinal Fascia Iliaca Block (SIFIB) for postoperative pain control in patients undergoing primary total hip arthroplasty. Effective analgesia after hip surgery is essential for early mobilization, reduction of complications, and improved recovery outcomes. Seventy patients scheduled for elective hip arthroplasty under spinal anesthesia will be randomly assigned to receive either DIPB or SIFIB at the end of surgery. Postoperative pain scores, opioid consumption, motor block, and block-related complications will be evaluated over a 48-hour period. The study aims to determine whether DIPB provides superior or comparable analgesia with reduced motor blockade compared to SIFIB, thereby contributing to safer and more comprehensive postoperative pain management in hip surgery patients.
Protocol Amendment History 1 change
critical Recruitment opened 2026-04-03
Trial Details
NCT Number NCT07452120
Lead Sponsor Sivas Numune Hospital
Conditions Hip Arthroplasty, Postoperative Pain, Regional Anesthesia, Acute Postoperative Pain
Enrollment 70 participants
Start Date 2026-03-27
Primary Completion 2026-10-01 (estimated)
Study Completion 2026-11-01 (estimated)
Updated on ClinicalTrials.gov 2026-04-02